Development of the glucuronyltransferase and sulphotransferase towards 2-naphthol in human fetus.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Developmental Pharmacology and Therapeutics

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1159/000480927PMID 2517106
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Renal glucuronidation of morphine in the human foetus.

  2009cited by this paper
• Morphine glucuronidation in human fetal and adult liver

  2004cited by this paper
• Glutathione S-transferase in humans: development and tissue distribution

  2004cited by this paper
• Sulfotransferase in humans: development and tissue distribution.

  1988cited by this paper
• Conjugation of styrene oxide by the basic and acidic forms of glutathione transferase in the human fetal liver.

  1988cited by this paper
• Kinetic and inhibitor studies of 4-methylumbelliferone and 1-naphthol glucuronidation in human liver microsomes.

  1988cited by this paper
• Sulphation and glucuronidation of ethinyloestradiol in human liver in vitro.

  1988cited by this paper
• Isolation and purification of two human liver UDP-glucuronosyltransferases.

  1987cited by this paper
• Development of multiple activities of UDP-glucuronyltransferase in human liver.

  1987cited by this paper
• Indirect evidences of UDP-glucuronosyltransferase heterogeneity: how can it help purification?

  1987cited by this paper
• Acetyltransferase in humans: development and tissue distribution.

  1986cited by this paper
• Studies of UDP-glucuronyltransferase activities in human liver microsomes.

  1984cited by this paper
• Sulphate and glucuronic acid conjugation of harmol in human fetal and adult liver tissue.

  1982cited by this paper
• Postnatal development of uridine diphosphate glucuronyltransferase activity towards bilirubin and 2-aminophenol in human liver.

  1979cited by this paper
• Determination of microsomal UDP-glucuronyltransferase in needle-biopsy specimens of human liver

  1978cited by this paper
• Functional heterogeneity of UDP-glucuronosyltransferase as indicated by its differential development and inducibility by glucocorticoids. Demonstration of two groups within the enzyme's activity towards twelve substrates.

  1978cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Developmental Pharmacokinetics of Antibiotics Used in Neonatal ICU: Focus on Preterm Infants

  2023cites this paper
• Use of Developmental Midazolam and 1-Hydroxymidazolam Data with Pediatric Physiologically Based Modeling to Assess Cytochrome P450 3A4 and Uridine Diphosphate Glucuronosyl Transferase 2B4 Ontogeny In Vivo

  2023influential citation
• The Environmental Pollutant Bromophenols Interfere With Sulfotransferase That Mediates Endocrine Hormones

  2022cites this paper
• Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species

  2021cites this paper
• An investigation of systemic exposure to bisphenol AF during critical periods of development in the rat.

  2020cites this paper
• Personalized pediatric anesthesia and pain management: problem-based review.

  2020cites this paper
• Potential implications of DMET ontogeny on the disposition of commonly prescribed drugs in neonatal and pediatric intensive care units

  2020cites this paper
• Epigenetic modifications associated with in utero exposure to endocrine disrupting chemicals BPA, DDT and Pb

  2019cites this paper
• Ontogeny of Hepatic Sulfotransferases and Prediction of Age-Dependent Fractional Contribution of Sulfation in Acetaminophen Metabolism

  2019cites this paper
• MEST mediates the impact of prenatal bisphenol A exposure on long-term body weight development

  2018cites this paper
• Updated perspectives on the cytosolic sulfotransferases (SULTs) and SULT-mediated sulfation

  2017cites this paper
• Maternal Codeine and Its Effect on the Fetus and Neonate: A Focus on Pharmacogenomics, Neuropathology, and Withdrawal

  2016cites this paper
• Exposure to butyl paraben during gestation and lactation in Hsd:Sprague dawley SD rats via dosed feed

  2016cites this paper
• Genetic variation, expression and ontogeny of sulfotransferase SULT2A1 in humans

  2015cites this paper
• Pharmacokinetics of Morphine and Its Metabolites in Infants and Young Children After Congenital Heart Surgery

  2015cites this paper
• Paediatric oral biopharmaceutics: key considerations and current challenges.

  2014cites this paper
• Regulation of Xenobiotic Metabolism in the Liver

  2014cites this paper
• Clinical Pharmacology of Furosemide in Neonates: A Review

  2013cites this paper
• Tissue Distribution and Relative Gene Expression of UDP-Glucuronosyltransferases (2B7, 2B15, 2B17) in the Human Fetus

  2013cites this paper
• DMD049197 291..295

  2013cites this paper
• Pharmacogenetics and anesthetic drugs.

  2012cites this paper
• Age‐Dependent Expression of Human Drug‐Metabolizing Enzymes

  2012cites this paper
• Ontogeny of mammalian metabolizing enzymes in humans and animals used in toxicological studies

  2012cites this paper
• Cytostatic drugs in infants: a review on pharmacokinetic data in infants.

  2012cites this paper
• Pediatric models for adult target‐controlled infusion pumps

  2010cites this paper
• Ontogeny of hepatic drug metabolizing enzymes in sheep

  2010influential citation
• Intravenous neonatal paracetamol dosing: the magic of 10 days

  2009cites this paper
• Mechanistic basis of using body size and maturation to predict clearance in humans.

  2009cites this paper
• Pediatric Palliative Care

  2009cites this paper
• Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial.

  2008cites this paper
• The ontogeny of drug metabolism enzymes and implications for adverse drug events.

  2008cites this paper
• Mechanism-based concepts of size and maturity in pharmacokinetics.

  2008cites this paper
• Pharmacological research in pediatrics: From neonates to adolescents.

  2006cites this paper
• Population clinical pharmacology of children: modelling covariate effects

  2006cites this paper
• Role of Xenobiotic Metabolism in Developmental and Reproductive Toxicity

  2005cites this paper
• Newborns and drug studies: the NICHD/FDA newborn drug development initiative.

  2005cites this paper
• Ontogeny of drug metabolizing enzymes in the neonate.

  2005cites this paper
• The pharmacological treatment of neonatal pain.

  2005cites this paper
• Embryonic turkey liver: activities of biotransformation enzymes and activation of DNA-reactive carcinogens

  2004influential citation
• Sulphation and glucuronidation of ritodrine in human foetal and adult tissues

  2004cites this paper
• Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children.

  2004cites this paper
• Morphine more fine? Its effects in critically ill newborns

  2004cites this paper
• Role of biokinetics in risk assessment of drugs and chemicals in children.

  2004cites this paper
• Pharmacokinetics in the newborn.

  2003cites this paper
• Use of genetically manipulated Salmonella typhimurium strains to evaluate the role of sulfotransferases and acetyltransferases in nitrofen mutagenicity.

  2003cites this paper
• Paediatric pain management: from personal-biased to evidence-based

  2002cites this paper
• Developmental aspects of human hepatic drug glucuronidation in young children and adults

  2002cites this paper
• Correlation of Urinary 1-Hydroxypyrene and 2-Naphthol with Total Suspended Particulates in Ambient Air in Municipal Middle-School Students in Korea

  2002cites this paper
• Ontogeny of Hepatic and Renal Systemic Clearance Pathways in Infants Part I

  2002cites this paper
• Reverse geometrical selectivity in glucuronidation and sulfation of cis- and trans-4-hydroxytamoxifens by human liver UDP-glucuronosyltransferases and sulfotransferases.

  2002cites this paper
• Approaches to Studying the Development of Drug Metabolism in Children

  2002cites this paper
• SIDS Initial Assessment Report For

  2002cites this paper
• Developmental aspects of midazolam metabolism

  2001cites this paper
• Chapter Glucuronidation in humans : Pharmacogenetic and developmental aspects 3

  2001cites this paper
• Effects of occupation, lifestyle and genetic polymorphisms of CYP1A1, CYP2E1, GSTM1 and GSTT1 on urinary 1-hydroxypyrene and 2-naphthol concentrations.

  2001cites this paper
• Neonatal hepatic drug elimination.

  2001cites this paper
• Human adult and foetal liver sulphotransferases: inhibition by mefenamic acid and salicylic acid

  2001cites this paper
• Hormonally Active Drugs and the Fetus

  2001cites this paper
• Uridine 5′ — Diphosphoglucuronic acid (UDPGLcUA) in the human fetal liver, kidney and placenta

  2000cites this paper
• Pharmacokinetics and pharmacodynamics of analgesic drugs

  2000cites this paper
• Assay of 2-naphthol in human urine by high-performance liquid chromatography.

  1999cites this paper
• Glucuronidation in Humans

  1999cites this paper
• Fetal hepatic drug elimination.

  1999cites this paper
• Toxicokinetics in infants and children in relation to the ADI and TDI.

  1998cites this paper
• Zidovudine glucuronidation in human liver: interindividual variability.

  1996cites this paper
• Conjugation of para-nitrophenol by isolated perfused fetal sheep liver.

  1996cites this paper
• Conjugation of benzoic acid with glycine in human liver and kidney: a study on the interindividual variability.

  1993cites this paper
• Conjugation of benzoic acid with glycine in the human fetal and adult liver and kidney.

  1991cites this paper
• Fetal Drug Metabolism and Its Possible Clinical Implications

  1991cites this paper
• Dopamine sulphotransferase is better developed than p-nitrophenol sulphotransferase in the human fetus.

  1991cites this paper
• Human liver sulphotransferase and UDP-glucuronosyltransferase: structure-activity relationship for phenolic substrates.

  1991cites this paper